-
5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide
-
ChemBase ID:
178686
-
Molecular Formular:
C22H25FN4O2
-
Molecular Mass:
396.4579032
-
Monoisotopic Mass:
396.19615428
-
SMILES and InChIs
SMILES:
c1cc2c(cc1F)/C(=C/c1c(c(c([nH]1)C)C(=O)NCCN1CCCC1)C)/C(=O)N2
Canonical SMILES:
Fc1ccc2c(c1)/C(=C/c1[nH]c(c(c1C)C(=O)NCCN1CCCC1)C)/C(=O)N2
InChI:
InChI=1S/C22H25FN4O2/c1-13-19(12-17-16-11-15(23)5-6-18(16)26-21(17)28)25-14(2)20(13)22(29)24-7-10-27-8-3-4-9-27/h5-6,11-12,25H,3-4,7-10H2,1-2H3,(H,24,29)(H,26,28)/b17-12-
InChIKey:
SRSGVKWWVXWSJT-ATVHPVEESA-N
-
Cite this record
CBID:178686 http://www.chembase.cn/molecule-178686.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide
|
|
|
IUPAC Traditional name
|
5-{[(3Z)-5-fluoro-2-oxo-1H-indol-3-ylidene]methyl}-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide
|
|
|
Synonyms
|
5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide
|
5-(5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid (2-(Pyrrolidin-1-yl)ethyl)amide
|
PHA 291639
|
SU 11654
|
ToceranibDiscontinued Pfizer Patent issues
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
11.461624
|
H Acceptors
|
3
|
H Donor
|
3
|
LogD (pH = 5.5)
|
-0.186452
|
LogD (pH = 7.4)
|
1.5766504
|
Log P
|
2.6195583
|
Molar Refractivity
|
114.3101 cm3
|
Polarizability
|
41.401566 Å3
|
Polar Surface Area
|
77.23 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
true
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
T525500
|
Toceranib is a multitargeted indolinone receptor tyrosine kinase (RTK) inhibitor. Toceranib exhibited activity against a variety of spontaneous malignancies in canine such as mast cell tumors, mixed mammary carcinomas, soft tissue sarcomas, and multiple m |
PATENTS
PATENTS
PubChem Patent
Google Patent